Evidence map›Paper›PMID 21704722›Full record

ReviewProstaglandins & other lipid mediators2011

Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission.

Stanley I Rapoport, Epolia Ramadan, Mireille Basselin

Abstract readReview
In one paragraph

Review in Prostaglandins & other lipid mediators, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Neurodegeneration with brain iron accumulation.Handbook of clinical neurology · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Stanley I RapoportBrain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Epolia Ramadan
Mireille Basselin
Institute on Aging · USNational Institutes of Health · US

Funding

Imaging Brain Signal Transduction via Arachidonic and Docosahexaenoic AcidsZIAAG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2015
$3.3M
Brain Imaging In Human Aging, Alzheimer Disease And Other DisordersZIAAG000148 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2016
$1.4M
THE NERVOUS SYSTEM IN RELATION TO FUNCTION, AGING, AND DISEASEZ01AG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 1985 to 2008
$1.2M
Brain Imaging In Human Aging and Alzheimers DiseaseZ01AG000148 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2001 to 2008
$241k
Intramural NIH HHS Z01 AG000134Intramural NIH HHS Z01 AG000148
6 · The paper itself

Abstract

Docosahexaenoic acid (DHA) is critical for maintaining normal brain structure and function, and is considered neuroprotective. Its brain concentration depends on dietary DHA content and hepatic conversion from its dietary derived n-3 precursor, α-linolenic acid (α-LNA). We have developed an in vivo method in rats using quantitative autoradiography and intravenously injected radiolabeled DHA to image net incorporation into the brain of unesterified plasma DHA, and showed with this method that the incorporation rate of DHA equals the rate of brain metabolic DHA consumption. The method has been extended for use in humans with positron emission tomography (PET). Furthermore, imaging in unanesthetized rats using DHA incorporation as a biomarker in response to acute N-methyl-D-aspartate administration confirms that regional DHA signaling is independent of extracellular calcium, and likely mediated by a calcium-independent phospholipase A(2) (iPLA(2)). Studies in mice in which iPLA(2)-VIA (β) was knocked out confirmed that this enzyme is critical for baseline and muscarinic cholinergic signaling involving DHA. Thus, quantitative imaging of DHA incorporation from plasma into brain can be used as an in vivo biomarker of brain DHA metabolism and neurotransmission.

Indexed as

Brain Chemistryalpha-Linolenic AcidAnimalsAutoradiographyBiomarkersDocosahexaenoic AcidsHumansInjections, IntravenousMiceMice, KnockoutNeuroprotective AgentsN-MethylaspartatePhospholipases A2Positron-Emission TomographyRadionuclide ImagingRatsalpha-Linolenic AcidBiomarkersDocosahexaenoic AcidsNeuroprotective AgentsN-MethylaspartatePhospholipases A2

Identifiers

PMID21704722
PMCPMC3202024
OpenAlexW2003169732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.